171 – 180 of 316
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Reduced Body Mass Index in Parkinson's Disease: Contribution of Comorbid Depression.
(
- Contribution to journal › Article
-
Mark
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Mechanisms underlying cortical resonant states: implications for levodopa-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
(
- Contribution to journal › Article
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
(
- Contribution to journal › Article
-
Mark
Design of a Highly Selective and Potent Class of Non-planar Estrogen Receptor Agonists
(
- Contribution to journal › Article
-
Mark
Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
(
- Contribution to journal › Article